Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity

Six series of structurally different mono- and binuclear copper(II) complexes 5–10 were obtained by reacting N-(2-pyridyl)imidazolidin-2-ones (1a–l), N,N'-bis(2-pyridyl)imidazolidin-2-ones (2a,b), N-acyl-N'(2-pyridyl)imidazolodin-2-ones (3a–j) and N-(2-pyridyl)imidazolidine-2-thiones (4a...

Full description

Bibliographic Details
Main Authors: Łukasz Balewski, Franciszek Sączewski, Patrick J. Bednarski, Maria Gdaniec, Ewa Borys, Anna Makowska
Format: Article
Language:English
Published: MDPI AG 2014-10-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/19/10/17026
_version_ 1818480320986480640
author Łukasz Balewski
Franciszek Sączewski
Patrick J. Bednarski
Maria Gdaniec
Ewa Borys
Anna Makowska
author_facet Łukasz Balewski
Franciszek Sączewski
Patrick J. Bednarski
Maria Gdaniec
Ewa Borys
Anna Makowska
author_sort Łukasz Balewski
collection DOAJ
description Six series of structurally different mono- and binuclear copper(II) complexes 5–10 were obtained by reacting N-(2-pyridyl)imidazolidin-2-ones (1a–l), N,N'-bis(2-pyridyl)imidazolidin-2-ones (2a,b), N-acyl-N'(2-pyridyl)imidazolodin-2-ones (3a–j) and N-(2-pyridyl)imidazolidine-2-thiones (4a–g) with copper(II) chloride at an ambient temperature. The coordination modes of the complexes obtained were established by elemental analysis, IR spectroscopic data and single crystal X-ray diffraction studies. The in vitro cytotoxic activities of both the free ligands and copper(II) complexes were evaluated using a crystal violet microtiter plate assay on five human tumor cell lines: LCLC-103H, A-427, SISO, RT-4 and DAN-G. The free ligands 1–4 at concentration attainable in cancer cells of 20 μM showed no meaningful cytotoxic effect with cell viability in the range of 88%–100%. The most potent copper(II) complex of 1-(6-ethoxy-2-pyridyl)imidazolidin-2-one (6b) exhibited selective cytotoxicity against A-427 lung cancer cell line, while the complexes of 1-(5-methyl-2-pyridyl)imidazolidine-2-thione (5h) and 1-(4-tert-butyl-2-pyridyl)imidazolidine-2-thione (5j) showed cytostatic effect against a whole panel of five human tumor cell lines. In conclusion, the only complexes that showed remarkably increased activity in comparison to the free ligands were those obtained from N-(2-pyridyl)imidazolidine-2-thiones 4c and 4e substituted with alkyl group at position 4 or 5 of pyridine ring.
first_indexed 2024-12-10T11:21:55Z
format Article
id doaj.art-2088907406db403f9d05f52686f5e406
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-10T11:21:55Z
publishDate 2014-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-2088907406db403f9d05f52686f5e4062022-12-22T01:50:54ZengMDPI AGMolecules1420-30492014-10-011910170261705110.3390/molecules191017026molecules191017026Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor ActivityŁukasz Balewski0Franciszek Sączewski1Patrick J. Bednarski2Maria Gdaniec3Ewa Borys4Anna Makowska5Department of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandDepartment of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandDepartment of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, L.-F.-Jahn Str., D-17489 Greifswald, GermanyFaculty of Chemistry, A. Mickiewicz University, 60-780 Poznań, PolandDepartment of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandDepartment of Chemical Technology of Drugs, Faculty of Pharmacy, Medical University of Gdańsk, 80-416 Gdańsk, PolandSix series of structurally different mono- and binuclear copper(II) complexes 5–10 were obtained by reacting N-(2-pyridyl)imidazolidin-2-ones (1a–l), N,N'-bis(2-pyridyl)imidazolidin-2-ones (2a,b), N-acyl-N'(2-pyridyl)imidazolodin-2-ones (3a–j) and N-(2-pyridyl)imidazolidine-2-thiones (4a–g) with copper(II) chloride at an ambient temperature. The coordination modes of the complexes obtained were established by elemental analysis, IR spectroscopic data and single crystal X-ray diffraction studies. The in vitro cytotoxic activities of both the free ligands and copper(II) complexes were evaluated using a crystal violet microtiter plate assay on five human tumor cell lines: LCLC-103H, A-427, SISO, RT-4 and DAN-G. The free ligands 1–4 at concentration attainable in cancer cells of 20 μM showed no meaningful cytotoxic effect with cell viability in the range of 88%–100%. The most potent copper(II) complex of 1-(6-ethoxy-2-pyridyl)imidazolidin-2-one (6b) exhibited selective cytotoxicity against A-427 lung cancer cell line, while the complexes of 1-(5-methyl-2-pyridyl)imidazolidine-2-thione (5h) and 1-(4-tert-butyl-2-pyridyl)imidazolidine-2-thione (5j) showed cytostatic effect against a whole panel of five human tumor cell lines. In conclusion, the only complexes that showed remarkably increased activity in comparison to the free ligands were those obtained from N-(2-pyridyl)imidazolidine-2-thiones 4c and 4e substituted with alkyl group at position 4 or 5 of pyridine ring.http://www.mdpi.com/1420-3049/19/10/170261-(2-pyridyl)imidazolidin-2-ones1-(2-pyridyl)imidazolidine-2-thionescopper(II) complexesX-ray crystal structure analysis in vitro antitumor activity
spellingShingle Łukasz Balewski
Franciszek Sączewski
Patrick J. Bednarski
Maria Gdaniec
Ewa Borys
Anna Makowska
Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
Molecules
1-(2-pyridyl)imidazolidin-2-ones
1-(2-pyridyl)imidazolidine-2-thiones
copper(II) complexes
X-ray crystal structure analysis
in vitro antitumor activity
title Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
title_full Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
title_fullStr Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
title_full_unstemmed Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
title_short Structural Diversity of Copper(II) Complexes with N-(2-Pyridyl)Imidazolidin-2-Ones(Thiones) and Their in Vitro Antitumor Activity
title_sort structural diversity of copper ii complexes with n 2 pyridyl imidazolidin 2 ones thiones and their in vitro antitumor activity
topic 1-(2-pyridyl)imidazolidin-2-ones
1-(2-pyridyl)imidazolidine-2-thiones
copper(II) complexes
X-ray crystal structure analysis
in vitro antitumor activity
url http://www.mdpi.com/1420-3049/19/10/17026
work_keys_str_mv AT łukaszbalewski structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity
AT franciszeksaczewski structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity
AT patrickjbednarski structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity
AT mariagdaniec structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity
AT ewaborys structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity
AT annamakowska structuraldiversityofcopperiicomplexeswithn2pyridylimidazolidin2onesthionesandtheirinvitroantitumoractivity